Phanes Advances Spevatamig to Expansion in BTC Trial
SAN DIEGO, April 7, 2026 Phanes Therapeutics, Inc. has announced the initiation of the dose expansion phase in its...
spevatamig
Advertisement
Advertisement
Advertisement
SAN DIEGO, April 7, 2026 Phanes Therapeutics, Inc. has announced the initiation of the dose expansion phase in its...
Advertisement